Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prospects in the management of patients with follicular lymphoma beyond first-line therapy. | Haematologica | 2022 | 34985231 | PubTator, text mining | PubMed |
| B cell class switching in intestinal immunity in health and disease. | Scand J Immunol | 2022 | 34978077 | PubTator, text mining | PubMed |
| FcγRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape. | Theranostics | 2022 | 34976216 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes and signaling pathways in neutrophils during sepsis-induced immunosuppression via bioinformatics analysis. | Chin Med J (Engl) | 2022 | 34966028 | PubTator, text mining | PubMed |
| Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability. | Nat Cell Biol | 2022 | 34961794 | PubTator, text mining | PubMed |
| Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2022 | 34953792 | PubTator, text mining | PubMed |
| The evolution of powerful yet perilous immune systems. | Trends Immunol | 2022 | 34949534 | PubTator, text mining | PubMed |
| Aberrant expression of inhibitory receptors on B cells in patients with Graves' disease. | Hum Immunol | 2022 | 34933777 | PubTator, text mining | PubMed |
| Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells. | MAbs | 2022 | 34923915 | PubTator, text mining | PubMed |
| The role of lysosomes in alpha-synucleinopathies: a focus on glial cells. | Neural Regen Res | 2022 | 34916427 | PubTator, text mining | PubMed |
| FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer. | Clin Cancer Res | 2022 | 34916216 | PubTator, text mining | PubMed |
| IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti-B Cell Therapies. | Neurol Neuroimmunol Neuroinflamm | 2022 | 34845096 | PubTator, text mining | PubMed |
| Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. | EMBO Mol Med | 2022 | 34842342 | PubTator, text mining | PubMed |
| Autoimmunity in motion: Mechanisms of immune regulation and destruction revealed by in vivo imaging. | Immunol Rev | 2022 | 34825390 | PubTator, text mining | PubMed |
| Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab? | Rheumatology (Oxford) | 2022 | 34788412 | PubTator, text mining | PubMed |
| Are humanized IgE reporter systems potential game changers in serological diagnosis of human parasitic infection? | Parasitol Res | 2022 | 34767081 | PubTator, text mining | PubMed |
| Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. | Neurol Neuroimmunol Neuroinflamm | 2022 | 34728497 | PubTator, text mining | PubMed |
| Human immune polymorphisms associated with the risk of cryptococcal disease. | Immunology | 2022 | 34716931 | PubTator, text mining | PubMed |
| Comprehensive phenotyping of human peripheral blood B lymphocytes in healthy conditions. | Cytometry A | 2022 | 34664397 | PubTator, text mining | PubMed |
| B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. | Ann Rheum Dis | 2022 | 34615636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=54